Patent ID: 11866431
Assignee: VIVACE THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 7:
8. The compound of claim 1, or a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate thereof, wherein:
each R2 is independently —CN, —OR3, —SR3, —S(═O)2R3, —N(R3)2, —C(═O)OR3, —N3, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C1-C6haloalkyl, substituted or unsubstituted C1-C6heteroalkyl, substituted or unsubstituted C3-C10cycloalkyl, or substituted or unsubstituted C2-C10heterocycloalkyl; and
each R3 is independently hydrogen, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C1-C6haloalkyl, substituted or unsubstituted C1-C6heteroalkyl, substituted or unsubstituted C3-C10cycloalkyl, or substituted or unsubstituted C2-C10heterocycloalkyl.